✉news HealthMedicine first seen 2 d ago, last 2 d ago, peak #36
Eli Lilly trial shows new drug achieves significant weight loss
Eli Lilly reports that a new drug under development achieved significant weight loss in a clinical trial. The results add to the company's portfolio of obesity treatments, a market where it already competes with drugs such as Zepbound. Details of the trial, including the size of the weight loss and patient outcomes, are drawing attention from investors and the medical community.
Why now: Obesity drug results from Eli Lilly carry major commercial and health implications amid the booming weight-loss treatment market
Evidence
- eli lilly trial shows new drug achieves significant weight loss · BusinessWorld Online
API: https://socialmediatrends-api.osmike.com/v1/trends/909441